When do you prefer commodities over equities?

The onslaught of supply concerns and increasing demand drives the commodity prices. Increasing inflation favours exposure to commodities as opposed to equities.

What exchange platform do this product cover for commodities trading?

This product covers commodities trading on COMEX, LME, NYMEX, ICE and CBOT.

What is the time frame for this report?

Being a technical analysis report, the recommendation is provided for a short-term view.

AU & Global Healthcare News | Stocks & Market Updates

PYC Therapeutics Ltd (ASX:PYC) joins broader sector advance

PYC Therapeutics Ltd (ASX:PYC) traded at $1.65, +1.54%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. PYC Therapeutics Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to …

Sonal Goyal | 29 July 2026

Nanosonics Ltd (ASX:NAN) climbs following inflation slowdown

Nanosonics Ltd (ASX:NAN) traded at $3.135, +2.79%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Nanosonics Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to 27,125.20 points, …

Sonal Goyal | 29 July 2026

Ebos Group Ltd (ASX:EBO) soars on positive market sentiment

Ebos Group Ltd (ASX:EBO) traded at $18.54, +3.17%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Ebos Group Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to …

Sonal Goyal | 29 July 2026

What's happening to Fisher & Paykel Healthcare (ASX:FPH) stock?

Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) traded at $34.545, +2.90%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Fisher & Paykel Healthcare Corporation Ltd outperformed the S&P/ASX 200 Health …

Sonal Goyal | 29 July 2026

Integral Diagnostics Ltd (ASX:IDX) advances with healthcare equities

Integral Diagnostics Ltd (ASX:IDX) traded at $2.10, +0.96%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Integral Diagnostics Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to …

Sonal Goyal | 29 July 2026

Imricor Medical Systems (ASX:IMR) pressured amid broader gains

Imricor Medical Systems Inc (ASX:IMR) traded at $1.91, -2.05%, during trading on 29 July 2026. The company declined during the session as the broader healthcare sector continued its positive momentum. Imricor Medical Systems Inc underperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% …

Sonal Goyal | 29 July 2026

Mesoblast Ltd (ASX:MSB) slips as sector surges - what's next?

Mesoblast Ltd (ASX:MSB) traded at $2.04, -0.97%, during trading on 29 July 2026. The company declined during the session as the broader healthcare sector continued its positive momentum. Mesoblast Ltd underperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to 27,125.20 points, reflecting …

Sonal Goyal | 29 July 2026

Ansell Ltd (ASX:ANN) rides healthcare sector momentum wave

Ansell Ltd (ASX:ANN) traded at $33.47, +2.42%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Ansell Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to 27,125.20 points, …

Sonal Goyal | 29 July 2026

Artrya Ltd (ASX:AYA) declines despite sector strength - why

Artrya Ltd (ASX:AYA) traded at $4.88, -4.13%, during trading on 29 July 2026. The company declined during the session as the broader healthcare sector continued its positive momentum. Artrya Ltd underperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to 27,125.20 points, reflecting …

Sonal Goyal | 29 July 2026

Cochlear Ltd (ASX:COH) stock up - here's why

Cochlear Ltd (ASX:COH) traded at $121.90, +1.69%, during trading on 29 July 2026. The company traded higher during the session as the broader healthcare sector continued its positive momentum. Cochlear Ltd outperformed the S&P/ASX 200 Health Care Index, which advanced 3.77% to 27,125.20 points, …

Sonal Goyal | 29 July 2026

Healthcare

PYC Therapeutics Ltd (ASX:PYC) joins broader sector advance

Nanosonics Ltd (ASX:NAN) climbs following inflation slowdown

Ebos Group Ltd (ASX:EBO) soars on positive market sentiment

What's happening to Fisher & Paykel Healthcare (ASX:FPH) stock?

Integral Diagnostics Ltd (ASX:IDX) advances with healthcare equities

Imricor Medical Systems (ASX:IMR) pressured amid broader gains

Mesoblast Ltd (ASX:MSB) slips as sector surges - what's next?

Ansell Ltd (ASX:ANN) rides healthcare sector momentum wave

Artrya Ltd (ASX:AYA) declines despite sector strength - why

Cochlear Ltd (ASX:COH) stock up - here's why

Latest News

Senetas Corporation Passes All Seven Resolutions at 2026 Annual General Meeting on 13 November

Yandal Resources Calls General Meeting to Ratify 94.2 Million Placement Shares and Approve Director Participation

Fulcrum Lithium to Release 58,600,005 Shares from Mandatory Escrow on 24 November 2026

Centrepoint Alliance Issues Virtual Access Update for 13 November 2026 Annual General Meeting

archTIS AGM Results: Six Resolutions Voted on 13 November 2026, Performance Rights for CEO Not Carried

Carma Limited Chair and CEO Address 2026 AGM: 5,416 Cars Delivered, Revenue Reaches $113.8 Million